Journal of Organometallic Chemistry p. C33 - C36 (1980)
Update date:2022-08-05
Topics:
Seitz, David E.
Tonnesen, Glenn L.
Hellman, Samuel
Hanson, Robert N.
Adelstein, S. James
A procedure has been developed for the synthesis of iodotamoxifen 3 from tamoxifen 1, an anti-estrogenic agent currently employed in the treatment of breast cancer.Ortho-directed metalation of tamoxifen with sec-butyllithium at -78 deg C followed by addition of tri-n-butyltin chloride gave the stannyl derivative 2 in 98percent isolated yield.Iododestannylation of 2 at 0 deg C with iodine afforded the desired iodotamoxifen 3 in quantitative yield.The dimethylaminoethoxy group appears to be more strongly activating for ortho metalation than methoxy.
View MoreQuzhou Ruiyuan chemical Co., Ltd
Contact:+86-570-3039321/3039361/3039308
Address:18# Huayang Road,Quzhou High-tech Industrial Park, Zhejiang China.
HANGZHOU PANYU CHEMICAL CO.,LIMITED
Contact:+86-571-86578491
Address:Rm 605, NO.1870 Binsheng Road,Binjiang Dist, Hangzhou, China
HangZhou HuaYe Chemical Technology Co.,Ltd
Contact:+86-13505815007
Address:hangzhou
Hangzhou innopharma technology Co,.Ltd.(expird)
Contact:+86-13388601988
Address:Room845,lixin building, moganshan road, hangzhou, china
Suzhou Ryan Pharmachem Technology Co.,Ltd
Contact:+86-0512-68780025
Address:B-301,No.2 Taishan Road,Suzhou New District,Jiangsu,P.R. China
Doi:10.1021/jo00144a026
(1982)Doi:10.1021/acs.orglett.1c00314
(2021)Doi:10.1021/ic50218a076
(1981)Doi:10.1016/S0008-6215(00)84560-7
(1980)Doi:10.1016/j.bmcl.2004.06.067
(2004)Doi:10.1021/jm0304562
(2004)
